Patricia H Davis

Author PubWeight™ 26.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011 7.16
2 Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 2010 2.39
3 Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study. J Am Coll Cardiol 2009 1.91
4 Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011 1.65
5 Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. Leuk Lymphoma 2011 1.51
6 Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study. Arterioscler Thromb Vasc Biol 2006 1.19
7 Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium. Int J Epidemiol 2012 1.10
8 Moyamoya-induced paroxysmal dyskinesia. Mov Disord 2003 1.01
9 Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome. Arch Neurol 2009 1.00
10 Can we predict early recurrence in acute stroke? Cerebrovasc Dis 2004 0.90
11 Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians. Arch Neurol 2007 0.84
12 Improving prediction of outcome in "good grade" subarachnoid hemorrhage. Neurosurgery 2007 0.83
13 Blood pressure as an independent prognostic factor in acute ischemic stroke. Can J Neurol Sci 2006 0.80
14 Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies. Leuk Lymphoma 2013 0.79
15 Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack. Stroke 2010 0.79
16 Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol 2005 0.76
17 "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. Biol Blood Marrow Transplant 2009 0.76
18 The NIHSS supplementary motor scale: a valid tool for multidisciplinary recovery trials. Cerebrovasc Dis 2013 0.75